Renal outcomes of treatment with telmisartan in patients with stage 3–4 chronic kidney disease: A prospective, randomized, controlled trial (JINNAGA)

OBJECTIVES: Although angiotensin II receptor blockers are effective for patients with chronic kidney disease, dose-dependent renoprotective effects of angiotensin II receptor blockers in patients with moderate to severe chronic kidney disease with non-nephrotic proteinuria are not known. Our aim was...

Descripción completa

Detalles Bibliográficos
Autores principales: Kitamura, Mineaki, Arai, Hideyuki, Abe, Shinichi, Ota, Yuki, Muta, Kumiko, Furusu, Akira, Mukae, Hiroshi, Kohno, Shigeru, Nishino, Tomoya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7686635/
https://www.ncbi.nlm.nih.gov/pubmed/33282300
http://dx.doi.org/10.1177/2050312120973502

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7686635/
https://www.ncbi.nlm.nih.gov/pubmed/33282300
http://dx.doi.org/10.1177/2050312120973502

Ejemplares similares